2m 2m 2m 2m 2m 2m 2m
UROGEN PHARMA (URGN)
NASDAQ
$35.16+$0.010 (+0.03%)
Price as of Oct 22, 2026 7:30 PM EDT- $1.7BMarket Cap
- 102.83%1-Year Change
- BiotechnologyIndustry
UROGEN PHARMA (URGN)
$35.16+$0.010 (+0.03%)
Earnings Score
Valuation | URGN | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | 0 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | URGN | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -1.02% | ||
12-Month Momentum | 135.73% | ||
3-Month Risk Adjusted Momentum | -4.28% | ||
12-Month Risk Adjusted Momentum | 217.98% |
True Yield
Valuation | URGN | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | 0.11% |
Financial Health Score
Valuation | URGN | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 4 |